Cargando…
Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question
The association of non-hereditary (sporadic) gastrointestinal stromal tumors (GISTs) and second primary malignancies is known to be nonrandom, although the underlying molecular mechanisms remain unknown. In this study, 136 of 749 (18.1%) patients with sporadic GISTs were found to have additional ass...
Autores principales: | Lai, Bo-Ru, Wu, Yu-Tung, Kuo, Yung-Chia, Hsu, Hung-Chih, Chen, Jen-Shi, Chen, Tse-Ching, Wu, Ren-Chin, Chiu, Cheng-Tang, Yeh, Chun-Nan, Yeh, Ta-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347768/ https://www.ncbi.nlm.nih.gov/pubmed/27806309 http://dx.doi.org/10.18632/oncotarget.12452 |
Ejemplares similares
-
Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()
por: Chen, Yen-Yang, et al.
Publicado: (2014) -
A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas
por: Espejo, Andrea P, et al.
Publicado: (2018) -
Hereditary and Acquired Characteristics as Social Questions
por: Kime, R. R.
Publicado: (1901) -
Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
por: Chen, Jen-Shi, et al.
Publicado: (2018) -
Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)